$RYAN

Ryan Specialty (RYAN): Vulcan Value Partners reports 7.9M-share, 6.11% stake

Ryan Specialty Holdings (RYAN) says Vulcan Value Partners, a Delaware investment adviser, filed an amended Schedule 13G showing 7,912,669 shares, or 6.11% of the class, as of June 30, 2026. Vulcan reports sole voting power over 5,011,724 shares and sole dispositive power over 7,912,669 shares for advisory clients.

Original reporting
Published Aug 7, 2026, 9:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 4:07 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$RYAN
Neutral
medium confidence
Mentioned
$RYAN
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$RYANNeutralLow
01

Why it matters

For traders, the main actionable element is the updated disclosed stake size and voting/dispositive power, which can influence near-term positioning but does not, by itself, change Ryan Specialty’s fundamentals.

02

Market read

Disclosed stake update to 6.11% with sole voting and dispositive power over the reported shares, but no control-seeking or corporate action is described.

03

What to watch

The filing disclaims beneficial ownership by Vulcan itself and attributes shares to advisory clients, which can reduce the predictability of follow-on actions.

Relevance 4/10Novelty 5/10Timing: after-hours filing disclosure dated Aug 7, 2026

Background

The article summarizes an amended SEC Schedule 13G filing by Vulcan Value Partners, a registered investment adviser, regarding its clients’ beneficial ownership in Ryan Specialty Holdings.

Company-level read

Ticker impact

$RYANNeutralMedium confidence
Context

Vulcan Value Partners filed an amended Schedule 13G showing 7,912,669 shares, or 6.11% of Ryan Specialty, as of June 30, 2026.

Expected impact

Low likelihood of a sustained price move solely from this filing; any reaction is likely limited to positioning/flow expectations.

Evidence & confidence

The article reports a Schedule 13G amendment (beneficial ownership disclosure) with no stated intent to seek control, no transaction, and no fundamental operating change.

Market effects

Minor read-through for specialty insurance brokerage ownership patterns, but no sector-wide regulatory or earnings signal is provided.

None indicated.

None indicated.

Counterpoint

A 6.11% stake could still be meaningful if the investor later escalates to a 13D or seeks board engagement, so the filing may be an early signal rather than a one-off disclosure.

Key entities

  • Ryan Specialty Holdings, Inc.

    US-listed specialty insurance brokerage whose common stock is the subject of the Schedule 13G amendment.

  • Vulcan Value Partners, LLC

    Delaware investment adviser filing the amended Schedule 13G for advisory clients’ beneficial ownership.

  • SEC Schedule 13G

    Disclosure form used for passive beneficial ownership reporting under the Securities Exchange Act.

Related articles

$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

$RYANMed

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Results of Operations and Financial Condition

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ryan-20260630xex991.htm EX-99.1 RYAN-2026.06.30-EX 99.1 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 pe